Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-04-009074
Filing Date
2004-09-13
Accepted
2004-09-13 16:24:13
Documents
8
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 VIRAGEN INC. g90918e10vk.htm 10-K 931937
2 SUBSIDIARIES OF THE COMPANY g90918exv21w1.htm EX-21.1 7352
3 CONSENT OF ERNST & YOUNG LLP g90918exv23w1.htm EX-23.1 3433
4 SEC 302 CHIEF EXECUTIVE OFFICER CERTIFICATION g90918exv31w1.htm EX-31.1 4967
5 SEC 302 CHIEF FINANCIAL OFFICER CERTIFICATION g90918exv31w2.htm EX-31.2 4970
6 SEC 906 CHIEF EXECUTIVE OFFICER CERTIFICATION g90918exv32w1.htm EX-32.1 3061
7 SEC 906 CHIEF FINANCIAL OFFICER CERTIFICATION g90918exv32w2.htm EX-32.2 3099
8 GRAPHIC g90918g9091800.gif GRAPHIC 33058
  Complete submission text file 0000950144-04-009074.txt   994413
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338746
VIRAGEN INC (Filer) CIK: 0000353482 (see all company filings)

EIN.: 592101668 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-15823 | Film No.: 041027758
SIC: 2836 Biological Products, (No Diagnostic Substances)